August 27, 2026

BioXcel Therapeutics, Inc.

Track this case

Case Number:

1:26-bk-11360

Court:

Delaware

Nature of Suit:

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 29, 2026

    BioXcel Seeks OK For $9.8M Deal With Investors

    Artificial intelligence-powered pharmaceutical group BioXcel has asked a Delaware bankruptcy judge to sign off on a $9.75 million settlement between the debtor and plaintiffs in a securities class action against it, saying the agreement will put one of the company's more important prepetition liabilities to bed.

8 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS